Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
And the Beat Goes On: APTA's Commercial Payer Advocacy

Apr 21, 2021/Roundup

Lots of payers with multiple plans mean the conversation never stops. Here are a few advocacy efforts that APTA is pursuing.

Educational Leadership Conference Focuses on Creating a Sustainable Future

Aug 20, 2021/News

The Oct. 22-24 event is built around the importance of developing habits than can ensure a strong future for physical therapy education.

APTA's Leadership in Health and Wellness Recognized by HHS

Jan 20, 2023/News

The association is now a "Healthy People 2030 Champion," joining a nationwide, multi-organization network.

Aotearoa New Zealand Autism Spectrum Disorder Guideline: Third Edition

Jan 1, 2022/CPG

This guideline, from the New Zealand government, is for people with autism spectrum disorder (ASD), their families and carers, health and disability professionals, community supporters, employers, policy advisers, and anyone involved in education. Recommendations address diagnosis and initial assessment,

Bills To Expand Telehealth to PTs and PTAs Now in Both Senate and House

Nov 15, 2021/News

The Senate version of the Expanded Telehealth Access Act is helping to build momentum for change.

Veterans Affairs and TRICARE

VA and TRICARE are major health systems in which PTs and PTAs play a major role. APTA can help you understand how they work.

APTA Outstanding Research Award

Awards

This award encourages the publication of outstanding physical therapy research articles, including both foundational and clinical research impacting practice and patient care.

What's New at ChoosePT.com: Expanded Consumer Info, Growing Directory of PTs

Jun 14, 2022/Roundup

APTA members benefit from millions of consumer visits and an enriched consumer-focused website. Here's what’s new.

Physical Therapy and Occupational Therapy Provide Significant Rehabilitative Value in Postacute Care

Apr 5, 2021/Statement

Study across 1.4 million Medicare cases indicates patients receiving these therapies have better quality of life and fewer hospital readmissions.